Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2016; 6(11): 087-093


Extracts of Codiaeum variegatum (L.) A. Juss is Cytotoxic on Human Leukemic, Breast and Prostate Cancer Cell Lines

Mathias Tawiah Anim, Christopher Larbie, Regina Appiah-Opong, Isaac Tuffour, Kofi Baffour-Awuah Owusu, Abigail Aning.




Abstract

The high cost of treatment of cancer coupled with the emergence of drug resistance makes it imperative for new drug interventions to curb its occurrence. Hence, the objective of this research was to determine the phytochemical, total phenolic content, antioxidant and antiproliferative effect of Codiaeum variegatum crude extracts and fractions. The MTT cell viability and DPPH assays among others were used to determine the selected properties of the plants. The presence of general glycosides, tannins, alkaloids, flavonoids and sterols was observed in its stem bark and leaf. Triterpenoids were present in the leaf only while saponins were observed in the stem bark only. Strong antioxidant activities were observed in both stem bark and leaf with EC50 values of 0.053±0.004 mg/mL and 1.396±0.073 mg/mL respectively. Both crude extracts showed antiproliferative activity towards all cancer cell lines with the stem bark exhibiting the strongest cytotoxicity. However, both showed strong cytotoxicity towards normal cells as well. The mechanism of cell death was determined to be apoptosis. Further testing of fractions from its stem bark crude extract revealed an increase in cytotoxicity of its chloroform fraction against Jurkat cells with an IC50 of 44.71±0.44 µg/mL. These results confirm the cytotoxicity of this plant.

Key words: Antiproliferative, Codiaeum variegatum, Apoptosis, Cytotoxicity, Fractionation, antioxidant






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.